ALT FY 2015 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$335M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+4.4% YoY

Gross Profit

$6M52.4% margin

Operating Income

-$3M-32.0% margin

Net Income

-$3M-32.3% margin

EPS (Diluted)

$-16.13

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$613,017

Balance Sheet

Total Assets

$20M

Total Liabilities

$3M

Stockholders' Equity

$17M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$10M	+4.4%
Gross Profit	$6M	$6M	-5.9%
Operating Income	-$3M	-$10M	+66.6%
Net Income	-$3M	-$10M	+65.4%